Korelasi Derajat Obstruksi Dengan Transpor Mukosiliar Hidung Penderita Penyakit Paru Obstruksi Kronik Stabil Di RSUP H. Adam Malik dan BP4 Medan
DAFTAR PUSTAKA
1. Perhimpunan Dokter Paru Indonesia (PDPI). PPOK (Penyakit Paru Obstruksi Kronik),
pedoman praktis diagnosis dan penatalaksanaan di Indonesia; 2011
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis,
management and prevention of chronic obstructive lung disease updated 2011.
3. Perhimpunan Dokter Paru Indonesia (PDPI). PPOK (Penyakit Paru Obstruksi Kronik),
pedoman praktis diagnosis dan penatalaksanaan di Indonesia; 2003.
4. Robert A. Chronic Obstructive Pulmonary Disease: Clinical Course and Management. In
Fishman’s
Pulmonary
Disease
and
disorder.
4th
ed.
Philadelphia:
MCGraw-
Hill;2007;p.731-33.
5. American Thoracic Society. Standards for diagnosis and management of patients with
COPD.2004.
6. Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ,Wedzicha JA. Effect of
exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J
Respir Crit Care Med 1998;157(5 Pt 1):1418–1422.
7. Borja G. Cosio and Alvar A. Update in Chronic Obstrucitve Pulmonary Disease Pulmonary
and Critical Care Update; 2009: 656-57.
8. Viegi G, Pistelli F, Maio S, Baldacci S, Carrozzi L. Definition, Epidemiology and Natural
History of COPD. Eur Respir J 2007; 30: 993-1013.
9. Raherison C, Girodet P.O. Epidemiology of COPD. Eur Respir Rev 2009; 18114: 213-221.
10. Yunus F. Tinjauan Kepustakaan Penatalaksanaan Penyakit Paru Obstruksi. Cermin Dunia
Kedokteran. Bagian Pulmonologi Fakultas Kedokteran Universitas Indonesia 1997; 114: 2832.
11. Wanner A, Salathe M, O’Riordan TG. Mucociliary clearance in the airways. Am J Respir
Crit Care Med 1996;154:1868–1902.
71
Universitas Sumatera Utara
12. Baratawidjaja KG. Sistem Immun, Dalam : Imunologi Dasar, Ed 8, Balai Penerbit Fakultas
Kedokteran UI, Jakarta, 2009; 27-93 8
13. PDPI. Mekanisme Pertahanan Paru, Pneumonia Komuniti Dalam : Pedoman Diagnosis dan
Penatalaksanaan di Indonesia, Balai Penerbit UI, Jakarta 2003; 2
14. Mason CM, Weinacker AB, Shellito JE. Host Defence Network in the Lung: An overview,
in : Respiratory Infections 2nd Ed, Philadelphia, WB. Saunders Company, 1994; 7-15
15. Feldmen Charles Nonspesific Host Defenses : Mucociliary Clearence and Cough, In :
Respiratory Infections, 2nd Ed, Philadelphia, WB. Saunders Company, 1994; 17-28
16. Jeffries Angus, Turley Andrew. Defence Mechanism of the lung, In : Respiratory System,
United Kingdom, Mosby, 2008 ; 36-39
17. Ballenger JJ, 1994, Aplikasi Klinis Anatomi dan Fisiologi Hidung dan Sinus Paranasal
dalam Penyakit Telinga,Hidung Tenggorok, Kepala dan Leher, Jilid 2, Edisi 13, Bina Rupa
Aksara, Jakarta, 1-25
18. Hilger PA, 1997, Hidung : Anatomi dan Fisiologi Terapan, dalam Boies Buku Ajar Penyakit
THT, Edisi 6, Jakarta,173-89
19. Watelet JB.Bachert C, Gevaert P, Cauwenberge PV. 2002, Wound Healing of the Nasal and
Paranasal Mucosa: A Review.Am J Rhinol,16:77-84
20. Waguespack R, 1995, Mucociliary Clearance Patterns Following Endoscopic Sinus Surgery,
Laryngoscope (Supplement), 105, 1-40
21. Selby CD. Defence And Disordered Defence, In : Respiratory Medicine, United Kingdom,
Churchill Livingstone, 2002 ; 10-1 6
22. Chow WC, Moraes JT. Host Defences, In : Clinical Respiratory Medicine, 3th Ed, Vol.1,
Mosby, China, 2008; 165-76 11
23. Michael JW, McCray PB. Transport Function of Airway Epithelia and Submucosal Glands,
In : Fishman’s Pulmonary Diseases and Disorders, 4th Ed, Vol.1, McGraw-Hill, USA, 2008;
72
Universitas Sumatera Utara
137-145
24. McCaffrey TV, 1997, Mucociliary Transport, in : Rhinologi Diagnosis and Treatment,
Thiema Medical Publishers, New York, 155-73
25. Sakakura Y, 1997, Mucociliary Transport in Rhinologic Disease, in Bunnag C,
Muntharbornk, Asean Rhinological Practice, Siriyot Co, Ltd, Bangkok, 13
26. Gosepath J, Grebneva MD, 2002, Topical antibiotic, Antifungal and Antiseptic
Solution
Decrease Ciliary Activity in Nasal Respiratory Cell, Am J Rhinol ,vol 16, 25-31
27. Michael S, Benninger MD, 1998, Nasal mucociliary transport after exposure to swimming
pool water, Am J Rhinol, vol 8, 207-9.
28. Sastroasmoro S, Ismael Sofyan. Dasar – dasar Metodologi Penelitian Klinis. Ed ke 3, 2010.
Sagung Seto, Jakarta 323.
29. Koblizek V et al. Mucociliary clearance of COPD patients. Czech Republic. 2005.
30. Permatasari A. Efek pemberian inhalasi salbutamol secara nebulisasi sesaat sebelum
fisioterapi dada terhadap faal paru penderita PPOK stabil [tesis]. Medan: Program
Pendidikan Dokter Spesialis I Penyakit Paru FK USU. 2003.
31. Nainggolan N. Pengaruh Inhalasi tiotropium bromida terhadaap faal paru penderita PPOK
stabil derajat sedang di RSUP.H.Adam Malik Medan [tesis]. Medan: Program Pendidikan
Dokter Spesialis I Penyakit Paru FK USU. 2006.
32. Ritonga A. Profil Penderita Penyakit Paru Obstruksi Kronik Stabil Berdasarkan Penilaian
BODE Index di
RSUP H.Adam Malik dan RS PTP II Tembakau Deli Medan (tesis).
Medan : Program Pendidikan Dokter Spesialis dan Magister Kedokteran I. Penyakit Paru
FK USU. 2011
33. Purba Y.M. Profil Penderita Penyakit Paru Obstruksi Kronik Stabil di Rumah Sakit Umum
Pusat Haji Adam Malik Medan, Rumah Sakit Umum Tembakau Deli Medan dan Rumah
73
Universitas Sumatera Utara
Sakit Umum Pirngadi Medan Januari 2010 hingga Januari 2011(tesis). Medan : Program
Pendidikan Dokter Spesialis dan Magister Kedokteran I. Penyakit Paru FK USU. 2011.
34. Nungtjik K.A. et al. Efikasi Pemberian Kombinasi Inhalasi Salmeterol dan Flutikason
Propionat Melalui Alat Diskus pada Penyakit Paru Obstruktif Kronik. Departemen
Pulmonologi
dan
llmu
Kedoheran
Respirasi
Fakultas
Kedokteran
Universitas
Indonesia,Rumah Sakit Persahabatan, Jakarta dalam ” Majalah Kedokteran Indonesia “
Volum: 60, Nomor : 12, Desember 2010, hal 546 – 553.
35. Andersen 1, Proctor DF. Measurement of nasal mucociliary clearance. Eur J Respir Dis
1983;64 (suppl 127):37-40.
36. Stanley P, MacWilliam L, Greenstone M, Mackay I, Cole P. Efficacy of a saccharin test for
screening to detect abnormal mucociliary clearance. Br J Dis Chest 1984;78:62-5.
74
Universitas Sumatera Utara
1. Perhimpunan Dokter Paru Indonesia (PDPI). PPOK (Penyakit Paru Obstruksi Kronik),
pedoman praktis diagnosis dan penatalaksanaan di Indonesia; 2011
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis,
management and prevention of chronic obstructive lung disease updated 2011.
3. Perhimpunan Dokter Paru Indonesia (PDPI). PPOK (Penyakit Paru Obstruksi Kronik),
pedoman praktis diagnosis dan penatalaksanaan di Indonesia; 2003.
4. Robert A. Chronic Obstructive Pulmonary Disease: Clinical Course and Management. In
Fishman’s
Pulmonary
Disease
and
disorder.
4th
ed.
Philadelphia:
MCGraw-
Hill;2007;p.731-33.
5. American Thoracic Society. Standards for diagnosis and management of patients with
COPD.2004.
6. Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ,Wedzicha JA. Effect of
exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J
Respir Crit Care Med 1998;157(5 Pt 1):1418–1422.
7. Borja G. Cosio and Alvar A. Update in Chronic Obstrucitve Pulmonary Disease Pulmonary
and Critical Care Update; 2009: 656-57.
8. Viegi G, Pistelli F, Maio S, Baldacci S, Carrozzi L. Definition, Epidemiology and Natural
History of COPD. Eur Respir J 2007; 30: 993-1013.
9. Raherison C, Girodet P.O. Epidemiology of COPD. Eur Respir Rev 2009; 18114: 213-221.
10. Yunus F. Tinjauan Kepustakaan Penatalaksanaan Penyakit Paru Obstruksi. Cermin Dunia
Kedokteran. Bagian Pulmonologi Fakultas Kedokteran Universitas Indonesia 1997; 114: 2832.
11. Wanner A, Salathe M, O’Riordan TG. Mucociliary clearance in the airways. Am J Respir
Crit Care Med 1996;154:1868–1902.
71
Universitas Sumatera Utara
12. Baratawidjaja KG. Sistem Immun, Dalam : Imunologi Dasar, Ed 8, Balai Penerbit Fakultas
Kedokteran UI, Jakarta, 2009; 27-93 8
13. PDPI. Mekanisme Pertahanan Paru, Pneumonia Komuniti Dalam : Pedoman Diagnosis dan
Penatalaksanaan di Indonesia, Balai Penerbit UI, Jakarta 2003; 2
14. Mason CM, Weinacker AB, Shellito JE. Host Defence Network in the Lung: An overview,
in : Respiratory Infections 2nd Ed, Philadelphia, WB. Saunders Company, 1994; 7-15
15. Feldmen Charles Nonspesific Host Defenses : Mucociliary Clearence and Cough, In :
Respiratory Infections, 2nd Ed, Philadelphia, WB. Saunders Company, 1994; 17-28
16. Jeffries Angus, Turley Andrew. Defence Mechanism of the lung, In : Respiratory System,
United Kingdom, Mosby, 2008 ; 36-39
17. Ballenger JJ, 1994, Aplikasi Klinis Anatomi dan Fisiologi Hidung dan Sinus Paranasal
dalam Penyakit Telinga,Hidung Tenggorok, Kepala dan Leher, Jilid 2, Edisi 13, Bina Rupa
Aksara, Jakarta, 1-25
18. Hilger PA, 1997, Hidung : Anatomi dan Fisiologi Terapan, dalam Boies Buku Ajar Penyakit
THT, Edisi 6, Jakarta,173-89
19. Watelet JB.Bachert C, Gevaert P, Cauwenberge PV. 2002, Wound Healing of the Nasal and
Paranasal Mucosa: A Review.Am J Rhinol,16:77-84
20. Waguespack R, 1995, Mucociliary Clearance Patterns Following Endoscopic Sinus Surgery,
Laryngoscope (Supplement), 105, 1-40
21. Selby CD. Defence And Disordered Defence, In : Respiratory Medicine, United Kingdom,
Churchill Livingstone, 2002 ; 10-1 6
22. Chow WC, Moraes JT. Host Defences, In : Clinical Respiratory Medicine, 3th Ed, Vol.1,
Mosby, China, 2008; 165-76 11
23. Michael JW, McCray PB. Transport Function of Airway Epithelia and Submucosal Glands,
In : Fishman’s Pulmonary Diseases and Disorders, 4th Ed, Vol.1, McGraw-Hill, USA, 2008;
72
Universitas Sumatera Utara
137-145
24. McCaffrey TV, 1997, Mucociliary Transport, in : Rhinologi Diagnosis and Treatment,
Thiema Medical Publishers, New York, 155-73
25. Sakakura Y, 1997, Mucociliary Transport in Rhinologic Disease, in Bunnag C,
Muntharbornk, Asean Rhinological Practice, Siriyot Co, Ltd, Bangkok, 13
26. Gosepath J, Grebneva MD, 2002, Topical antibiotic, Antifungal and Antiseptic
Solution
Decrease Ciliary Activity in Nasal Respiratory Cell, Am J Rhinol ,vol 16, 25-31
27. Michael S, Benninger MD, 1998, Nasal mucociliary transport after exposure to swimming
pool water, Am J Rhinol, vol 8, 207-9.
28. Sastroasmoro S, Ismael Sofyan. Dasar – dasar Metodologi Penelitian Klinis. Ed ke 3, 2010.
Sagung Seto, Jakarta 323.
29. Koblizek V et al. Mucociliary clearance of COPD patients. Czech Republic. 2005.
30. Permatasari A. Efek pemberian inhalasi salbutamol secara nebulisasi sesaat sebelum
fisioterapi dada terhadap faal paru penderita PPOK stabil [tesis]. Medan: Program
Pendidikan Dokter Spesialis I Penyakit Paru FK USU. 2003.
31. Nainggolan N. Pengaruh Inhalasi tiotropium bromida terhadaap faal paru penderita PPOK
stabil derajat sedang di RSUP.H.Adam Malik Medan [tesis]. Medan: Program Pendidikan
Dokter Spesialis I Penyakit Paru FK USU. 2006.
32. Ritonga A. Profil Penderita Penyakit Paru Obstruksi Kronik Stabil Berdasarkan Penilaian
BODE Index di
RSUP H.Adam Malik dan RS PTP II Tembakau Deli Medan (tesis).
Medan : Program Pendidikan Dokter Spesialis dan Magister Kedokteran I. Penyakit Paru
FK USU. 2011
33. Purba Y.M. Profil Penderita Penyakit Paru Obstruksi Kronik Stabil di Rumah Sakit Umum
Pusat Haji Adam Malik Medan, Rumah Sakit Umum Tembakau Deli Medan dan Rumah
73
Universitas Sumatera Utara
Sakit Umum Pirngadi Medan Januari 2010 hingga Januari 2011(tesis). Medan : Program
Pendidikan Dokter Spesialis dan Magister Kedokteran I. Penyakit Paru FK USU. 2011.
34. Nungtjik K.A. et al. Efikasi Pemberian Kombinasi Inhalasi Salmeterol dan Flutikason
Propionat Melalui Alat Diskus pada Penyakit Paru Obstruktif Kronik. Departemen
Pulmonologi
dan
llmu
Kedoheran
Respirasi
Fakultas
Kedokteran
Universitas
Indonesia,Rumah Sakit Persahabatan, Jakarta dalam ” Majalah Kedokteran Indonesia “
Volum: 60, Nomor : 12, Desember 2010, hal 546 – 553.
35. Andersen 1, Proctor DF. Measurement of nasal mucociliary clearance. Eur J Respir Dis
1983;64 (suppl 127):37-40.
36. Stanley P, MacWilliam L, Greenstone M, Mackay I, Cole P. Efficacy of a saccharin test for
screening to detect abnormal mucociliary clearance. Br J Dis Chest 1984;78:62-5.
74
Universitas Sumatera Utara